Basic information Safety Supplier Related

R-tetrahydropapaverine HCl

Basic information Safety Supplier Related

R-tetrahydropapaverine HCl Basic information

Product Name:
R-tetrahydropapaverine HCl
Synonyms:
  • R-tetrahydropapaverine HCl
  • R-(+)-TETRAHYDROPAPAVERIN HYDROCHLORIDE
  • (r)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline
  • (R)-1-(3,4-DIMETHOXY-BENZYL)-6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE HYDROCHLORIDE
  • R-(+)-Tetrahydropapaverin
  • (R)-1-(3,4-DIMETHOXY-BENZYL)-6,7-DIMETHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE HYDROCHLORID
  • R-Tetrahydropapaverine
  • R-BINAP
CAS:
54417-53-7
MF:
C20H26ClNO4
MW:
379.88
EINECS:
415-110-8
Product Categories:
  • Analgesic series
Mol File:
54417-53-7.mol
More
Less

R-tetrahydropapaverine HCl Chemical Properties

Boiling point:
475.8℃
Density 
1.32 at 22℃
vapor pressure 
0Pa at 25℃
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
color 
White to Off-White
InChI
InChI=1/C20H25NO4.ClH/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16;/h5-6,10-12,16,21H,7-9H2,1-4H3;1H/t16-;/s3
InChIKey
VMPLLPIDRGXFTQ-LSQUZMQTNA-N
SMILES
C(C1C=CC(OC)=C(OC)C=1)[C@H]1NCCC2=CC(OC)=C(OC)C=C12.Cl |&1:11,r|
LogP
-0.63 at 25℃
CAS DataBase Reference
54417-53-7(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22-52/53
Safety Statements 
22-61
More
Less

R-tetrahydropapaverine HCl Usage And Synthesis

Application

R-tetrahydropapaverine HCl is a useful research chemical.

Synthesis

6429-04-5

54417-53-7

The general procedure for the synthesis of the target compound using 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride as raw material was as follows: 20 g of 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride was dissolved in 400 mL of distilled water, and stirred until completely dissolved. Subsequently, ammonia was added to the solution to adjust the pH, and after observing that no white oily material precipitated, 400 mL of toluene was added and mixed with thorough stirring. The organic phase (toluene layer) and the aqueous phase were separated to ensure that there was no residual raw material in the aqueous phase. The organic phase was dried with anhydrous sodium sulfate to obtain 17.3 g of racemate. The racemate was dissolved in 173 mL of acetonitrile and heated to 70 °C. 3.93 g of the splitting agent N-acetyl-D-leucine was slowly added and the reaction was stirred for 20 minutes. Next, 0.522 g of the splitting agent N-acetyl-D-phenylalanine was added and the reaction was continued with stirring for 35 minutes. Upon completion of the reaction, it was slowly cooled to room temperature and subsequently stored in a refrigerator at 4°C for 24 hours to promote crystallization. Upon completion of crystallization, the solid product was collected by filtration. The product was converted to hydrochloride form, treated by adding appropriate amount of hydrochloric acid and dried to give 8.325 g of 1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride in R-configuration. The total yield was 83.25% and the purity was 97.6%.

References

[1] Patent: CN107056700, 2017, A. Location in patent: Paragraph 0040-0043; 0046; 0058

R-tetrahydropapaverine HClSupplier

Lianyungang Shenghe Biotechnology Co., Ltd. Gold
Tel
13585296001 13585296001
Email
haizaofu@163.com
Shandong Shenghe Pharmaceutical Technology Co. LTD Gold
Tel
13585296001
Email
haizaofu@163.com
Sichuan Mingjian Pharmaceutical Chemical Co., Ltd. Gold
Tel
15281098982
Email
sales@mjpharma.cn
TIANJIN PHARMACN MEDICAL TECHNOLOGY CO.,LTD.
Tel
022-60189726 18812034280
Email
188120342808@163.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com